Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?

Clinical & developmental immunology - 1 Jan 2013

Morscio J, Dierickx D, Tousseyn T

Abstract excerpt

Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal disease that arises in 2%-10% of solid organ and hematopoietic stem cell transplants and is most frequently of B-cell origin. This very heterogeneous disorder ranges from benign lymphoproliferations to malignant lymphomas, and despite the clear association with Epstein-Barr Virus (EBV) infection, its etiology is still obscure. Although a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epstein-Barr Virus Infections
Share to Genetic Heterogeneity

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Herpesvirus 4, Human

Share to Immunosuppression Therapy

Share to Lymphoproliferative Disorders

Share to Organ Transplantation

Share to Translocation, Genetic

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 23690819
DOI: 10.1155/2013/150835
PMCID: PMC3649442

Genes

MYC
IGH
PAX5
PIM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?PMID 23690819Read ↗

Posttransplant Lymphoproliferative DisordersSemantic proximity Read ↗

Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology.Semantic proximity Read ↗

Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis.Semantic proximity Read ↗

Epstein-Barr virus-associated posttransplant lymphoproliferative disorders: new insights in pathogenesis, classification and treatmentSemantic proximity Read ↗

Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.Semantic proximity Read ↗

Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disordersSemantic proximity Read ↗

Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling.Semantic proximity Read ↗

Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.Semantic proximity Read ↗

Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.Semantic proximity Read ↗

Mutational landscape of B-cell post-transplant lymphoproliferative disorders.Semantic proximity Read ↗

Characteristic Pattern of Chromosomal Imbalances in Posttransplantation Lymphoproliferative Disorders: Correlation with Histopathological Subcategories and EBV StatusSemantic proximity Read ↗

Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.